Alkeon Capital Management LLC Ultragenyx Pharmaceutical Inc. Transaction History

Alkeon Capital Management LLC

$58.2 Billion
Q3 2024

A detailed history of Alkeon Capital Management LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Alkeon Capital Management LLC holds 3,011,716 shares of RARE stock, worth $147 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

3,011,716

Previous 2,241,832 34.34%

Holding current value

$147 Million

Previous $92.1 Million 81.57%

% of portfolio

0.29%

Previous 0.15%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$40.21 - $59.36 $31 Million - $45.7 Million	769,884 Added 34.34%	3,011,716 $167 Million
Q4 2023 Feb 13, 2024	BUY	$31.73 - $49.19 $9.46 Million - $14.7 Million	298,017 Added 15.33%	2,241,832 $107 Million
Q2 2023 Aug 11, 2023	BUY	$37.35 - $52.15 $3.67 Million - $5.12 Million	98,141 Added 5.32%	1,943,815 $89.7 Million
Q1 2023 May 12, 2023	SELL	$36.99 - $48.71 $320,074 - $421,487	-8,653 Reduced 0.47%	1,845,674 $74 Million
Q4 2022 Feb 13, 2023	SELL	$33.72 - $46.33 $12.1 Million - $16.6 Million	-357,632 Reduced 16.17%	1,854,327 $85.9 Million
Q3 2022 Nov 10, 2022	SELL	$39.96 - $66.14 $10.2 Million - $16.9 Million	-256,171 Reduced 10.38%	2,211,959 $91.6 Million
Q2 2022 Aug 15, 2022	BUY	$45.8 - $85.4 $4.58 Million - $8.54 Million	100,000 Added 4.22%	2,468,130 $147 Million
Q1 2022 May 16, 2022	BUY	$62.2 - $84.4 $3.73 Million - $5.06 Million	60,000 Added 2.6%	2,368,130 $172 Million
Q3 2021 Nov 15, 2021	BUY	$77.92 - $102.4 $30.7 Million - $40.4 Million	394,482 Added 20.61%	2,308,130 $208 Million
Q2 2021 Aug 16, 2021	BUY	$92.19 - $115.71 $55.3 Million - $69.4 Million	599,791 Added 45.65%	1,913,648 $182 Million
Q1 2021 May 17, 2021	BUY	$106.9 - $167.73 $321,982 - $505,202	3,012 Added 0.23%	1,313,857 $150 Million
Q4 2020 Feb 16, 2021	SELL	$84.4 - $177.39 $48 Million - $101 Million	-568,375 Reduced 30.25%	1,310,845 $181 Million
Q3 2020 Nov 16, 2020	BUY	$72.98 - $90.0 $7.3 Million - $9 Million	100,000 Added 5.62%	1,879,220 $154 Million
Q2 2020 Aug 14, 2020	BUY	$46.91 - $78.22 $7.44 Million - $12.4 Million	158,687 Added 9.79%	1,779,220 $139 Million
Q1 2020 May 15, 2020	BUY	$33.8 - $62.9 $8.11 Million - $15.1 Million	240,000 Added 17.38%	1,620,533 $72 Million
Q4 2019 Feb 14, 2020	SELL	$36.08 - $45.83 $7.44 Million - $9.45 Million	-206,200 Reduced 13.0%	1,380,533 $59 Million
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $4.89 Million - $7.26 Million	115,000 Added 7.81%	1,586,733 $67.9 Million
Q1 2019 May 15, 2019	BUY	$39.87 - $69.36 $26 Million - $45.2 Million	652,207 Added 79.58%	1,471,733 $102 Million
Q4 2018 Feb 14, 2019	BUY	$38.89 - $77.3 $3.04 Million - $6.05 Million	78,205 Added 10.55%	819,526 $35.6 Million
Q3 2018 Nov 14, 2018	BUY	$71.81 - $90.15 $18 Million - $22.5 Million	250,025 Added 50.89%	741,321 $56.6 Million
Q2 2018 Aug 14, 2018	BUY	$48.54 - $85.31 $23.8 Million - $41.9 Million	491,296 New	491,296 $37.8 Million

Others Institutions Holding RARE

# of Institutions

305

Shares Held

87.5M

Call Options Held

588K

Put Options Held

244K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.41B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alkeon Capital Management LLC with notifications on news.

Account

Alkeon Capital Management LLC Ultragenyx Pharmaceutical Inc. Transaction History